Transition of LINE-1 DNA Methylation Status and Altered Expression in First and Third Trimester Placentas

por He, Zhi-ming, Li, Jinping, Hwa, Yi Lisa, Brost, Brian, Fang, Qun, Jiang, Shi-Wen
Publicado 2014

Primary adenomyoepithelioma of tonsil

por Ren, Juan, Song, Liping, Dang, Qiang, Zhang, Xiaozhi, Jiang, Shi-Wen, Zhang, Guanjun, Wang, Ning, Liu, Zi, Wang, Jiansheng, Hwa, Yi Lisa, Li, Zongfang, Zhao, Xinhan, Liu, Yuan
Publicado 2010

Primary adenomyoepithelioma of tonsil

por Ren, Juan, Song, Liping, Dang, Qiang, Zhang, Xiaozhi, Jiang, Shi-Wen, Zhang, Guanjun, Wang, Ning, Liu, Zi, Wang, Jiansheng, Hwa, Yi Lisa, Li, Zongfang, Zhao, Xinhan, Liu, Yuan
Publicado 2010

Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response to Therapy

por Moustafa, Muhamad Alhaj, Rajkumar, S. Vincent, Dispenzieri, Angela, Gertz, Morie A., Lacy, Martha Q., Buadi, Francis K., Hwa, Yi Lisa, Dingli, David, Kapoor, Prashant, Hayman, Suzanne R., Lust, John A., Kyle, Robert A., Kumar, Shaji K.
Publicado 2015

P-208: Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients

por Charalampous, Charalampos, Goel, Utkarsh, Kapoor, Prashant, Binder, Moritz, Buadi, Francis, Dingli, David, Dispenzieri, Angela, Fonder, Amie, Gertz, Morie, Gonsalves, Wilson, Hayman, Suzanne, Hobbs, Miriam, Hwa, Yi Lisa, Kourelis, Taxiarchis, Lacy, Martha, Leung, Nelson, Lin, Yi, Warsame, Rahma, Kyle, Robert, Rajkumar, Vincent, Kumar, Shaji
Publicado 2022

Outcomes after biochemical or clinical progression in patients with multiple myeloma

por Goldman-Mazur, Sarah, Visram, Alissa, Kapoor, Prashant, Dispenzieri, Angela, Lacy, Martha Q., Gertz, Morie A., Buadi, Francis K., Hayman, Suzanne R., Dingli, David, Kourelis, Taxiarchis, Gonsalves, Wilson, Warsame, Rahma, Muchtar, Eli, Leung, Nelson, Binder, Moritz, Fonder, Amie, Hobbs, Miriam, Hwa, Yi Lisa, Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K.
Publicado 2022

Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome

por Muchtar, Eli, Drake, Matthew T., Leung, Nelson, Dispenzieri, Angela, Lacy, Martha Q., Buadi, Francis K., Dingli, David, Hayman, Suzanne R., Kapoor, Prashant, Hwa, Yi Lisa, Fonder, Amie, Hobbs, Miriam, Gonsalves, Wilson, Kourelis, Taxiarchis V., Warsame, Rahma, Russell, Stephen, Go, Ronald S., Binder, Moritz, Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K., Gertz, Morie A.
Publicado 2022

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

por Sidiqi, M. Hasib, Aljama, Mohammed, Kumar, Shaji K., Jevremovic, Dragan, Buadi, Francis K., Warsame, Rahma, Lacy, Martha Q., Dingli, David, Gonsalves, Wilson I., Fonder, Amie L., Hobbs, Miriam A., Hwa, Yi Lisa, Kapoor, Prashant, Kourelis, Taxiarchis, Leung, Nelson, Muchtar, Eli, Lust, John A., Kyle, Robert A., Go, Ronald S., Rajkumar, Vincent S., Gertz, Morie A., Dispenzieri, Angela
Publicado 2020

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria

por Lakshman, Arjun, Rajkumar, S. Vincent, Buadi, Francis K., Binder, Moritz, Gertz, Morie A., Lacy, Martha Q., Dispenzieri, Angela, Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Hwa, Yi Lisa, Kapoor, Prashant, Leung, Nelson, Go, Ronald S., Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Lust, John A., Russell, Stephen J., Zeldenrust, Steven R., Kyle, Robert A., Kumar, Shaji K.
Publicado 2018

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

por Kumar, Shaji K., Buadi, Francis K., LaPlant, Betsy, Halvorson, Alese, Leung, Nelson, Kapoor, Prashant, Dingli, David, Gertz, Morie A., Go, Ronald S., Bergsagel, P. Leif, Lin, Yi, Dispenzieri, Angela, Hwa, Yi Lisa, Fonder, Amie, Hobbs, Miriam, Fonseca, Rafael, Hayman, Suzanne R., Stewart, A. Keith, Lust, John A., Mikhael, Joseph, Gonsalves, Wilson, Reeder, Craig, Skacel, Tomas, Rajkumar, S. Vincent, Lacy, Martha Q.
Publicado 2018

Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis

por Muchtar, Eli, Gertz, Morie A., LaPlant, Betsy R., Buadi, Francis K., Leung, Nelson, O’Brien, Patrick, Bergsagel, P. Leif, Fonder, Amie, Hwa, Yi Lisa, Hobbs, Miriam, Helgeson, Dania K., Bradt, Erin E., Gonsalves, Wilson, Lacy, Martha Q., Kapoor, Prashant, Siddiqui, Mustaqueem, Larsen, Jeremy T., Warsame, Rahma, Hayman, Suzanne R., Go, Ronald S., Dingli, David, Kourelis, Taxiarchis V., Dispenzieri, Angela, Rajkumar, S. Vincent, Kumar, Shaji K.
Publicado 2022

Natural history of multiple myeloma with de novo del(17p)

por Lakshman, Arjun, Painuly, Utkarsh, Rajkumar, S. Vincent, Ketterling, Rhett P., Kapoor, Prashant, Greipp, Patricia T., Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Dingli, David, Dispenzieri, Angela, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Hwa, Yi Lisa, Leung, Nelson, Go, Ronald S., Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Lust, John A., Russell, Stephen J., Zeldenrust, Steven R., Kyle, Robert A., Kumar, Shaji K.
Publicado 2019

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

por Dispenzieri, Angela, Arendt, Bonnie, Dasari, Surendra, Kohlhagen, Mindy, Kourelis, Taxiarchis, Kumar, Shaji K., Leung, Nelson, Muchtar, Eli, Buadi, Francis K., Warsame, Rahma, Kyle, Robert A., Lacy, Martha Q., Dingli, David, Kapoor, Prashant, Gonsalves, Wilson I., Go, Ronald S., Hayman, Suzanne R., Hwa, Yi Lisa, Fonder, Amy, Hobbs, Miriam, Jevremovic, Dragan, Lust, John A., Zeldenrust, Steven, Russell, Steve J., Rajkumar, S. Vincent, Gertz, Morie A., Murray, David
Publicado 2020